The results provide the first evidence that the miR‐134‐mediated post‐transcriptional regulation of CREB‐1 and BDNF is an important molecular mechanism underlying the plasticity deficit in AD; thus demonstrating the critical role of miR‐134‐5p as a potential therapeutic target for restoring plasticity in AD condition. Here, CREB1 is linked to Alzheimer disease.